Body care meizitang products can speed up the metabolism of users’ body

 Rimonabant (rimonabant in. SR141716) has entered Phase III clinical trials, can effectively reduce weight, and no significant adverse reactions. CB,-R blocker for the treatment of obesity is expected to bring a new dawn. So we can see, rimonabant The synthesis of great significance. Synthesis of 2.2 rimonabant: Rimonabant structured, we can see that rimonabant by several important part of the portfolio Form: acetone, chlorobenzene, 1 - amino the gung throat and 2, 4 twelve chlorobenzene navel. Chloropropiophenone alkali reagents.  The leading principle of the meizitang is to enhance the seepage force of cells.

  The body care meizitang can complement various nutrients that our body lacks.   Conclusion: Rimonabant is a selective cannabinoid receptor 1 (cannabinoid receptorl CBRl) blockers in fat Fat, smoking cessation and treatment of metabolic syndrome has a good effect, while improving a number of cardiovascular risk Factor is only used in the clinical control appetite and reduce weight within a cannabinoid receptor blocker. It by Sanofi -Aventis (formerly Sanofi-Synthelabo) development, ongoing schedule clinical study of this product. If its Phase III clinical listing will bring to the obesity treatment breakthrough.

Body care meizitang products can speed up the metabolism of users’ body.The thesis of their Synthetic methods were studied, the following conclusions: 1, chlorobenzene as raw materials, the synthesis of rimonabant were studied in chlorobenzene as raw materials, Phthalocyanine based, of Australia, replacing, condensation, cyclization, hydrolysis, phthalocyanine amination seven-step reaction synthesis of a Limo, That class. Through the reaction process of the test to get the best reaction conditions to improve yield and reduce theCost, suitable for industrial production, final product purification calculation.